insights_auto
Why is INO down 3,39%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,42 US$
arrow_downward
-3,39%(-0,050) 1D
12 ნოე, 09:40:06 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 US$
High
1,44 US$
Low
1,33 US$
Mkt. cap
266,01 მლნ.
Avg. vol.
19,06 მლნ.
Volume
202,12 ათ.
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
Open
1,44 US$
High
1,44 US$
Low
1,33 US$
Mkt. cap
266,01 მლნ.
Avg. vol.
19,06 მლნ.
Volume
202,12 ათ.
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
3 საათის წინ
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlights: FDA Approval, Commercial ...
GuruFocus
·
23 საათის წინ
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
1 დღის წინ
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
TradingView
·
1 დღის წინ
Key facts: INO Extends Runway; 2027 Launch; Data, Partner Search
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc